Potential tactics with certain gut microbiota for the treatment of unresectable hepatocellular carcinoma DOI Creative Commons
Sayuri Yoshikawa, Kurumi Taniguchi, Haruka Sawamura

и другие.

Exploration of Targeted Anti-tumor Therapy, Год журнала: 2023, Номер unknown, С. 556 - 568

Опубликована: Авг. 24, 2023

Hepatocellular carcinoma (HCC) constitutes an extremely malignant form of primary liver cancer. Intricate connections linking to the immune system might be associated with pathogenesis HCC. Meanwhile, immunotherapy checkpoint inhibitors has been established a favorable therapeutic possibility for advanced Although curative opportunities HCC are restricted, developed as main choice treating However, patients metabolic-associated fatty disease (MAFLD)-linked less likely benefit from alone. The limitation effect owing impaired T cell activation in MAFLD patients, which could well explained by dysfunctional gut-liver axis. Gut microbiota and their metabolites including several bile acids contribute modulating responses immunotherapy. Roles gut development cancers have expected great interest latest studies. Here, interplay between presented, suggest affect efficacy against

Язык: Английский

Therapeutic Implications of Probiotics in the Gut Microbe-Modulated Neuroinflammation and Progression of Alzheimer’s Disease DOI Creative Commons
Toshiyuki Murai, Satoru Matsuda

Life, Год журнала: 2023, Номер 13(7), С. 1466 - 1466

Опубликована: Июнь 28, 2023

Alzheimer’s disease (AD) is characterized by the accumulation of specific proteins in brain. A recent study revealed that manipulating gut microbiota (GM) significantly reduced tau pathology and neurodegeneration an apolipoprotein E isoform-dependent manner. The resilience a healthy protects it from variety dysbiosis-related pathologies. Convincing evidence has demonstrated roles GM pathogenesis AD, which are partly mediated modified microglial activity Therefore, modulation may be promising therapeutic option for AD prevention. In addition to providing cells with energy affecting maturation, these microbial metabolites appear influence neuronal function. One potential approaches targeting involve using probiotics. Additionally, human its have also become targets developing interventions prevention disorders. Synbiotics postbiotics can used treat modulating GM. addition, physical activity, exercise, fitness being considered as nonpharmacological therapies reduce signaling pathways related neuroinflammation. might strategies health promotion.

Язык: Английский

Процитировано

15

Potential Molecular Mechanisms of Alcohol Use Disorder with Non-Coding RNAs and Gut Microbiota for the Development of Superior Therapeutic Application DOI Open Access

Moeka Nakashima,

Naoko Suga,

Sayuri Yoshikawa

и другие.

Genes, Год журнала: 2024, Номер 15(4), С. 431 - 431

Опубликована: Март 29, 2024

Many investigations have evaluated the expression of noncoding RNAs (ncRNAs) as well their related molecular functions and biological machineries in individuals with alcohol dependence. Alcohol dependence may be one most prevailing psychological disorders globally, its pathogenesis is intricate inadequately comprehended. There substantial evidence indicating significant links between multiple genetic factors development In particular, critical roles ncRNAs been emphasized pathology mental illnesses, probably including comprehension action modification, furthermore, they emerged therapeutic targets for a variety psychiatric It worth mentioning that dysregulated has regularly detected An in-depth knowledge m6A modification valuable novel treatment against general, more profound understanding practical might make important contributions to precise diagnosis and/or actual management Here, this review, we mostly focused on up-to-date regarding alterations modifications Then, present prospects future research applications concept engram system.

Язык: Английский

Процитировано

2

Potential tactics with certain gut microbiota for the treatment of unresectable hepatocellular carcinoma DOI Creative Commons
Sayuri Yoshikawa, Kurumi Taniguchi, Haruka Sawamura

и другие.

Exploration of Targeted Anti-tumor Therapy, Год журнала: 2023, Номер unknown, С. 556 - 568

Опубликована: Авг. 24, 2023

Hepatocellular carcinoma (HCC) constitutes an extremely malignant form of primary liver cancer. Intricate connections linking to the immune system might be associated with pathogenesis HCC. Meanwhile, immunotherapy checkpoint inhibitors has been established a favorable therapeutic possibility for advanced Although curative opportunities HCC are restricted, developed as main choice treating However, patients metabolic-associated fatty disease (MAFLD)-linked less likely benefit from alone. The limitation effect owing impaired T cell activation in MAFLD patients, which could well explained by dysfunctional gut-liver axis. Gut microbiota and their metabolites including several bile acids contribute modulating responses immunotherapy. Roles gut development cancers have expected great interest latest studies. Here, interplay between presented, suggest affect efficacy against

Язык: Английский

Процитировано

1